DARPA works on Scalable, On-Demand Blood for Transfusions and customizing blood cells for vaccine and drug delivery
DARPA program decreases cost of pharmed blood and raises possibility of enhanced red blood cells that offer novel therapeutic benefits to recipients. DARPA created its Blood Pharming program to potentially relieve the shortage or blood by developing an automated culture and packaging system that would yield a fresh supply of transfusable red blood cells from …